“…Although ample evidence demonstrates better hemodynamic stability in patients treated with VVBP than in those treated with nonbypass crossclamp techniques, [42][43][44][45][46] data on intraoperative blood use, renal failure, and early mortality suggest that VVBP is not required in all transplant recipients. 3,23,36,37,47,48 VVBP was advocated to reduce the risk of perioperative renal failure 39,42 because the combination of hypoperfusion and venous hypertension during the anhepatic stage renders the kidneys particularly vulnerable to injury. [49][50][51] Renal perfusion pressure, an index of kidney perfusion and a guide to management during surgery, improved with the use of VVBP, 25,26,52 but higher…”